Syncom Formulations (India) Ltd's Stock Gains 8.42%, Catching Attention of MarketsMOJO

Sep 05 2024 01:50 PM IST
share
Share Via
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has gained attention in the stock market with its recent performance. On September 5th, the stock closed at Rs 22.79, showing a gain of 8.42%. The company has outperformed the sector by 7.81% and is currently trading close to its 52-week high. With consecutive rise in stock and trading above moving averages, it has strong potential for growth.

Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 5th, the company's stock gained 8.42%, closing at Rs 22.79. This positive movement has caught the attention of MarketsMOJO, who have given a 'Buy' call for the stock.

The stock is currently trading close to its 52-week high of Rs 23.07, with a difference of only 1.81%. This shows the strong potential for growth in the company's stock. In fact, Syncom Formulations (India) Ltd has outperformed the sector by 7.81% in today's trading session.

The company's stock has been on a consecutive rise for the past 2 days, with a total gain of 13.47%. This is a clear indication of the company's positive momentum and potential for further growth. Intraday, the stock touched a high of Rs 22.79, showing a significant increase of 9.04%.

Syncom Formulations (India) Ltd is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This further reinforces the company's strong performance and potential for future growth.

In comparison to the Sensex, Syncom Formulations (India) Ltd has outperformed with a 1-day performance of 7.85% against the Sensex's -0.14%. In the past month, the company's stock has shown a remarkable growth of 51.78%, while the Sensex has only grown by 4.42%.

With its recent positive performance and strong potential for growth, Syncom Formulations (India) Ltd is definitely a stock to watch out for in the pharma industry. Investors can consider adding this smallcap company to their portfolio for potential returns.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Syncom Formul. falling/rising?
Nov 25 2025 01:16 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 17 2025 08:10 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 16 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 15 2025 08:10 AM IST
share
Share Via